401 related articles for article (PubMed ID: 21834778)
1. Recent advances and patents in solid dispersion technology.
Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
[TBL] [Abstract][Full Text] [Related]
2. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
[TBL] [Abstract][Full Text] [Related]
3. Solubilization of poorly water-soluble drugs using solid dispersions.
Tran TT; Tran PH; Khanh TN; Van TV; Lee BJ
Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):122-33. PubMed ID: 23244679
[TBL] [Abstract][Full Text] [Related]
4. An Overview on Recent Patents and Technologies on Solid Dispersion.
Kaushik R; Budhwar V; Kaushik D
Recent Pat Drug Deliv Formul; 2020; 14(1):63-74. PubMed ID: 31951172
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
Kumar S; Gupta SK
Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
[TBL] [Abstract][Full Text] [Related]
6. Dosage form designs for the controlled drug release of solid dispersions.
Tran PHL; Tran TTD
Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566
[TBL] [Abstract][Full Text] [Related]
7. BCS class IV drugs: Highly notorious candidates for formulation development.
Ghadi R; Dand N
J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
[TBL] [Abstract][Full Text] [Related]
8. Oral fast-release solid dispersion-paradigm shift to nanoparticles.
Wong TW
Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):227-43. PubMed ID: 21834774
[TBL] [Abstract][Full Text] [Related]
9. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
10. Solid dispersions: a review.
Dhirendra K; Lewis S; Udupa N; Atin K
Pak J Pharm Sci; 2009 Apr; 22(2):234-46. PubMed ID: 19339238
[TBL] [Abstract][Full Text] [Related]
11. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
Vo CL; Park C; Lee BJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
[TBL] [Abstract][Full Text] [Related]
12. Controlled release systems containing solid dispersions: strategies and mechanisms.
Tran PH; Tran TT; Park JB; Lee BJ
Pharm Res; 2011 Oct; 28(10):2353-78. PubMed ID: 21553168
[TBL] [Abstract][Full Text] [Related]
13. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
Kumar S; Bhargava D; Thakkar A; Arora S
Crit Rev Ther Drug Carrier Syst; 2013; 30(3):217-56. PubMed ID: 23614647
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on Strategies Using Swellable Polymers in Solid Dispersions for Controlled Drug Release.
Tran TTD; Tran PHL
Curr Pharm Des; 2017; 23(11):1639-1648. PubMed ID: 27774901
[TBL] [Abstract][Full Text] [Related]
15. Delivery of poorly soluble compounds by amorphous solid dispersions.
Lee TW; Boersen NA; Hui HW; Chow SF; Wan KY; Chow AH
Curr Pharm Des; 2014; 20(3):303-24. PubMed ID: 23651395
[TBL] [Abstract][Full Text] [Related]
16. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
Bikiaris DN
Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug.
Malipeddi VR; Dua K; Awasthi R
Drug Deliv Transl Res; 2016 Oct; 6(5):540-50. PubMed ID: 27343081
[TBL] [Abstract][Full Text] [Related]
18. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
Baghel S; Cathcart H; O'Reilly NJ
J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
[TBL] [Abstract][Full Text] [Related]
19. Solid dispersion technology as a strategy to improve the bioavailability of poorly soluble drugs.
Cid AG; Simonazzi A; Palma SD; Bermúdez JM
Ther Deliv; 2019 Jun; 10(6):363-382. PubMed ID: 31094298
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Solid Dispersion Technology for Efficient Delivery of Poorly Water-Soluble Drugs.
Paudwal G; Rawat N; Gupta R; Baldi A; Singh G; Gupta PN
Curr Pharm Des; 2019; 25(13):1524-1535. PubMed ID: 31258070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
